Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

UGC prepares additional share issue

4/25/24 UGLD

Nornickel disclosed the amount of investments in the implementation of the new strategy

4/25/24 GMKN

Henderson's sales in Q1 rose 17.5%

4/25/24 HNFG

Court suspended X5 Retail Group's corporate rights

4/25/24 X5

Lenta began testing wine and food stores

4/25/24 LENT

Shareholders of NovaBev Group approved dividends for 2023

4/25/24 BELU

MMK reported for 3 months of 2024 by RAS

4/25/24 MAGN

MMK reported for 3 months of 2024 by IFRS

4/25/24 MAGN

Inter RAO reported for 3 months of 2024 by RAS

4/25/24 IRAO

VTB reported IFRS results for 3 months of 2024

4/25/24 VTBR